Patrys Stock

Patrys Revenue 2024

Patrys Revenue

2.85 M AUD

Ticker

PAB.AX

ISIN

AU000000PAB9

WKN

A0MU4Y

In 2024, Patrys's sales reached 2.85 M AUD, a -14.45% difference from the 3.33 M AUD sales recorded in the previous year.

The Patrys Revenue history

YEARREVENUE (undefined AUD)GROSS MARGIN (%)
20232.8599,93
20223.3399,89
20211.34100,12
20200.77368,77
20190.84337,53
20180.52547,52
20170.53535,99
20160.86329,55
20150.95299,32
20140.76375,00
20130.98290,82
20121.07266,36
20111.07266,36
20100.94303,19
20091.43199,30
20081.11256,76
20070.064750,00

Patrys Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Patrys, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Patrys from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Patrys’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Patrys. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Patrys’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Patrys’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Patrys’s growth potential.

Patrys Revenue, EBIT and net profit per share

DatePatrys RevenuePatrys EBITPatrys Net Income
20232.85 M AUD-7.06 M AUD-7.06 M AUD
20223.33 M AUD-6.78 M AUD-6.78 M AUD
20211.34 M AUD-4.06 M AUD-4.06 M AUD
2020772,840 AUD-2.75 M AUD-2.75 M AUD
2019844,370 AUD-3.41 M AUD-411,330 AUD
2018520,530 AUD-2.5 M AUD-2.5 M AUD
2017531,730 AUD-1.88 M AUD-1.06 M AUD
2016864,810 AUD-1.13 M AUD-1.08 M AUD
2015952,150 AUD-4.76 M AUD-8.47 M AUD
2014760,000 AUD-7.28 M AUD-7.29 M AUD
2013980,000 AUD-3.72 M AUD-3.53 M AUD
20121.07 M AUD-5.1 M AUD-5.11 M AUD
20111.07 M AUD-7.4 M AUD-7.42 M AUD
2010940,000 AUD-8.1 M AUD-7.54 M AUD
20091.43 M AUD-9.82 M AUD-8.66 M AUD
20081.11 M AUD-7.25 M AUD-7.32 M AUD
200760,000 AUD-1.62 M AUD-1.65 M AUD

Patrys stock margins

The Patrys margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Patrys. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Patrys.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Patrys's sales revenue. A higher gross margin percentage indicates that the Patrys retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Patrys's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Patrys's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Patrys's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Patrys. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Patrys's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Patrys Margin History

Patrys Gross marginPatrys Profit marginPatrys EBIT marginPatrys Profit margin
202399.93 %-247.61 %-247.61 %
202299.89 %-203.4 %-203.4 %
2021100.12 %-303.57 %-303.57 %
202099.93 %-355.64 %-355.64 %
201999.93 %-404.01 %-48.71 %
201899.93 %-479.75 %-479.75 %
201799.93 %-353.84 %-198.95 %
201699.93 %-130.92 %-124.97 %
201599.93 %-499.5 %-889.61 %
201499.93 %-957.89 %-959.21 %
201399.93 %-379.59 %-360.2 %
201299.93 %-476.64 %-477.57 %
201199.93 %-691.59 %-693.46 %
201099.93 %-861.7 %-802.13 %
200999.93 %-686.71 %-605.59 %
200899.93 %-653.15 %-659.46 %
200799.93 %-2,700 %-2,750 %

Patrys Aktienanalyse

What does Patrys do?

The company Patrys Ltd is a biotechnology company based in Perth, Australia. It was founded in 2001 by a team of scientists and investors with the aim of developing and marketing targeted cancer treatments. Patrys focuses on the development of monoclonal antibodies and peptides containing therapeutic agents for cancer treatment. The main business model of Patrys is to develop and market new treatment options for cancer patients. The company utilizes the latest advancements in cancer research to develop innovative therapies tailored to the specific characteristics of each type of cancer. Patrys collaborates with leading scientists, research organizations, and pharmaceutical companies to develop a comprehensive portfolio of cancer treatments. Patrys has different business areas, all focused on the development of cancer treatments. One of these areas is the field of monoclonal antibodies, where Patrys concentrates on developing antibodies that can recognize and target specific proteins in cancer tissue. Another area focuses on the development of peptides specifically tailored to cancer cells. Patrys' products cover a variety of cancer types, including lung cancer, breast cancer, prostate cancer, colorectal cancer, and leukemia. The company's leading product is currently the antibody therapeutic PAT-LM1, used for the treatment of lung cancer. PAT-LM1 is a monoclonal antibody that targets a specific protein in the tumor, effectively combating the disease. The drug is currently in phase II clinical trials and showing promising results. Patrys is a company operating in a growing market. The global demand for cancer treatments is increasing, and Patrys has established itself as a significant player in this field. The company has gained recognition in recent years for its innovative therapy approaches and strong research and development team. Patrys aims to provide cancer patients with real hope for a cure and improve their quality of life. Overall, Patrys is a company operating in a rapidly growing market with a promising future. The company has developed a wide range of cancer treatments and works closely with leading experts and pharmaceutical companies to strengthen its position as an innovative and relevant player in cancer research. Patrys has a clear vision that it pursues, presenting an opportunity to play a significant role in the near future in a rapidly growing and highly relevant market. Patrys ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Patrys's Sales Figures

The sales figures of Patrys originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Patrys’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Patrys's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Patrys’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Patrys stock

How much revenue did Patrys generate this year?

Patrys has achieved a revenue of 2.85 M AUD this year.

How much was the turnover of the company Patrys compared to the previous year?

The revenue of Patrys has increased by -14.45% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Patrys?

The revenue of Patrys is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Patrys measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Patrys so important for investors?

The revenue of Patrys is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Patrys pay?

Over the past 12 months, Patrys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Patrys is expected to pay a dividend of 0 AUD.

What is the dividend yield of Patrys?

The current dividend yield of Patrys is .

When does Patrys pay dividends?

Patrys pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Patrys?

Patrys paid dividends every year for the past 0 years.

What is the dividend of Patrys?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Patrys located?

Patrys is assigned to the 'Health' sector.

Wann musste ich die Aktien von Patrys kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Patrys from 9/11/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/11/2024.

When did Patrys pay the last dividend?

The last dividend was paid out on 9/11/2024.

What was the dividend of Patrys in the year 2023?

In the year 2023, Patrys distributed 0 AUD as dividends.

In which currency does Patrys pay out the dividend?

The dividends of Patrys are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Patrys

Our stock analysis for Patrys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Patrys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.